Picosecond and carefully controlled 1064 nm Nd:YAG approaches come up most often in the literature. No device suits every patient or every practice, though.
This guide compares the main treatment categories, shows where IPL and fractional lasers fit, explains how darker skin and PIH risk affect selection, and lists what clinical buyers should verify before purchasing a platform.
Key Takeaways
- The best laser depends on skin type, pigment depth, triggers, prior response, and protocol, not brand.
- Picosecond and low-fluence Q-switched 1064 nm Nd:YAG are the leading categories to evaluate.
- IPL is not a laser, and heat can worsen melasma.
- Diagnosis, conservative settings, photoprotection, and maintenance matter as much as the device.
Overview of Laser Treatments for Melasma in the United States
What melasma is, and why recurrence shapes expectations
Melasma is a chronic, acquired facial hyperpigmentation. Pigment can sit in the epidermis, the dermis, or both. Symmetrical patches are typical, and the course is relapsing with no established cure. The American Academy of Dermatology notes it may last years or a lifetime, so permanent removal is an unrealistic promise.
Supported triggers include UV, visible light, hormones, and genetic susceptibility. A 2024 review also links thermal exposure to melasma, which is why heat-generating devices need caution.
How categories differ
Devices vary in several technical ways:
- Pulse duration: picosecond (10^-12 s) versus nanosecond (10^-9 s)
- Thermal effect: photoacoustic fragmentation versus photothermal heating
- Delivery: ablative, non-ablative, fractional, or broad-spectrum light
- Depth: 532 nm targets superficial pigment, while 1064 nm reaches deeper
"Fractional" does not mean "ablative." Micro-lens arrays can fractionate pico delivery without breaking the skin surface.
Practices are weighing pico, Q-switched, microsecond, fractional, and IPL platforms because evidence, recurrence risk, and labeling differ for melasma versus generic pigment claims. The same device can produce different results depending on diagnosis, settings, operator training, and aftercare. So this guide compares categories, not brands.
Top / Best Laser Treatments for Melasma in the United States
Ranking criteria
Each category is judged on clinical evidence, control of heat and inflammation, relevance across skin types, setting flexibility, documented indications, and practical value for a US practice. Every option below covers mechanism and evidence, likely fit, and risks plus procurement questions.
Picosecond 1064 nm Nd:YAG Lasers
Mechanism and evidence. Very short pulses are thought to fragment pigment photoacoustically, with less cumulative heat than longer pulses. A 2023 meta-analysis of six RCTs found overall MASI improvement, with heterogeneity of I²=70%.
In a 60-patient trial of Fitzpatrick III-IV patients, a 2023 RCT showed week-24 MASI improvement of 35.9% for 1064 nm pico, versus 25.5% for 755 nm pico and 24.0% for 2% hydroquinone.
Superiority over Q-switched is unproven. An 18-patient split-face trial found no significant efficacy difference (P=.873), with 12.5% recurrence on each side at three months.
Fit. Clinicians weigh pigment depth, Fitzpatrick type, prior PIH, and whether a fractional or lens-array handpiece changes the goal. In a 30-patient split-face study, micro-lens arrays did not significantly change spot reduction, though six-month recurrence was 1 patient with arrays versus 6 without.
Darker skin is not universally safe. One participant per group in the 60-patient trial developed PIH.
Risks and procurement questions:
- Protocol variability and rebound pigmentation
- Device-specific FDA 510(k) status and cleared indications
- Wavelength options and pulse-duration control
- Cooling, handpieces, training, and service support
Some cleared records list melasma explicitly. The PicoWay 510(k) K220853 includes melasma in Fitzpatrick I-IV, for example. Always confirm the exact handpiece.
Low-Fluence 1064 nm Q-Switched Nd:YAG Lasers
Evidence. A 2022 systematic review covered 42 studies and 1,736 patients, mostly Fitzpatrick II-V. Those findings apply to low-fluence 1064 nm protocols, not every Q-switched device. A meta-analysis of 12 studies found no significant MASI difference versus drug comparators, and adding drugs beat laser alone.
Fit. Consensus guidance treats laser as an adjunct for selected resistant cases, not first-line monotherapy.
Limitations:
- Recurrence reported at 64%, 81%, and 100% at three months in different studies
- One series reported 20 of 34 relapsing by one year
- Mottled hypopigmentation and rebound, more often in Fitzpatrick IV-V
- Aggressive or repeated treatment risks persistent hypopigmentation
Buyer checks:
- Fluence adjustability, spot sizes, and repetition rates
- Cooling and test-spot workflow
- Operator experience and documented indications
Microsecond Non-Ablative Nd:YAG Systems
These systems use 1064 nm pulses of about 650 microseconds, longer than pico or nanosecond pulses, with a different thermal profile and intended effect.
The independent evidence is thin. A 2021 evaluation from UC San Diego authors followed 10 patients with no comparator. Most showed up to 25% improvement after two treatments. Manufacturer independence is unconfirmed.
A separate 2025 study (28 enrolled, 21 completed, mostly Fitzpatrick IV-V) added a microsecond component to low-fluence Q-switched treatment. Three-month relapse fell to 4.8% from 23.8%, but the difference faded by six and twelve months. That is combination evidence, not proof for stand-alone use.
Ask vendors about:
- Epidermal heating management, cooling, and test spots
- Skin types studied and applicable FDA indications
- Usable protocol and safety documentation
Fractional Lasers, Especially Non-Ablative Systems
Fractional injury may improve texture, but it also creates heat and inflammation. Results for melasma conflict:
| Study | Result |
|---|---|
| 1550 nm RCT, 20 women, Fitzpatrick II-V | Comparable to triple topical therapy; 5 relapses per group at six months |
| 1550 nm split-face RCT, 29 patients | Worse outcomes on the laser side; 31% developed PIH |
Ablative CO2 and Er:YAG carry more caution still. A 2024 review advises against routine use, and expert consensus does not support fractional or ablative monotherapy.
Consider fractional treatment only when melasma comes with texture concerns, and require evidence for the specific wavelength and skin type. Watch downtime, active tanning, recent procedures, and PIH in darker skin.
Procurement checks:
- Energy control and cooling
- Consumables, training, and complication management
IPL as a Non-Laser Comparator
IPL is a broad-spectrum, noncoherent flashlamp, not a laser. One FDA-cleared example spans 420-1200 nm, and spectra vary by device. It is mainly considered for mixed pigmentation, redness, or photodamage.
Evidence is mostly for combination care. A 2020 meta-analysis of 8 studies and 215 patients showed MASI improvement (SMD 0.61) for IPL-containing regimens. A 2004 trial found 39.8% versus 11.6% melanin-index improvement, with partial repigmentation by week 24 and transient PIH in two patients.
A 2017 review considers IPL best suited to Fitzpatrick I-III, since darker skin raises the risk of hitting normal epidermal pigment.
Compare filters, fluence control, pulse sequencing, cooling, test spots, training, and cleared indications. Do not market IPL as interchangeable with a melasma-specific laser.
How We Chose the Best Laser Treatments
Evidence and safety
We ranked evidence in this order: systematic reviews, randomized or controlled studies, dermatology guidance, and device documentation. Evidence for tattoo removal, sun spots, or wrinkles was kept separate from melasma evidence.
Safety review considered:
- Fitzpatrick type and PIH or hypopigmentation history
- Recent sun exposure or tanning, and active inflammation
- Medications and uncontrolled hormonal triggers
- Pregnancy: a 2017 review does not recommend cosmetic laser or IPL due to insufficient safety data
- Lactation: available safety data remain very limited
Technical and regulatory capability
We evaluated wavelength, pulse duration, fluence range, spot size, repetition rate, fractional delivery, cooling, and the ability to run conservative settings. Higher maximum fluence is headroom, not a treatment recommendation.
FDA 510(k) clearance means substantial equivalence for an intended use. It is not PMA approval or proof of superiority.
We compared the exact model, wavelength, handpiece, mode, and indication. A platform being "cleared" is not enough. We also verified contraindications, training, maintenance, warranty, and support.
Common selection mistakes
- Ranking by brand recognition
- Treating undiagnosed pigmentation
- Assuming stronger settings work better
- Ignoring total cost of ownership
- Promising one-session clearance
- Skipping budget for maintenance skincare and follow-up
Conclusion
The best laser for melasma matches the diagnosis, skin type, risk profile, and goals, and the provider's ability to deliver a conservative, evidence-informed protocol. No single platform ranks as best across every case.
Melasma is managed, not cured. Plan for photoprotection, trigger management, home care, follow-up, and possible maintenance treatments.
Clinical professionals and practice owners can use the Pico Laser Buyer's Guide to compare manufacturer-backed specifications, FDA 510(k) clearance information, and technical documentation across its research library of 16 pico laser platforms before making a procurement decision.
Frequently Asked Questions
Which laser is most effective for melasma?
Picosecond and carefully controlled 1064 nm Nd:YAG lasers are often cited as top options. Protocol, patient selection, and recurrence risk mean no universal winner, including versus Q-switched devices.
Is IPL effective for treating melasma?
IPL is not a laser. It may help selected patients with mixed pigmentation or redness, but evidence varies, and poor settings or patient selection can worsen melasma.
Can laser remove melasma completely?
Laser can reduce visible pigment but cannot remove the tendency to recur. Hormones, light, heat, and inadequate photoprotection can all bring it back, so maintenance matters.
What is the most effective treatment for melasma?
The AAD identifies no single best treatment. Plans are individualized around diagnosis, daily photoprotection with iron-oxide tinted sunscreen, topicals, trigger management, and selected procedures.
What is melasma?
Melasma is a chronic pattern of brown or gray-brown facial hyperpigmentation tied to melanocyte overactivity. Hormonal, environmental, and genetic factors all influence it.
What foods worsen melasma?
No established food list exists. A 2025 case-control study of 194 women found no difference in diet or antioxidant intake between groups. Ask a clinician before restricting foods.
